101 related articles for article (PubMed ID: 12661076)
1. Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages.
Miyake M; Oka Y; Minami T; Toguchi H; Odomi M; Ogawara K; Higaki K; Kimura T
J Pharm Sci; 2003 Apr; 92(4):911-21. PubMed ID: 12661076
[TBL] [Abstract][Full Text] [Related]
2. Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine.
Miyake M; Kamada N; Oka Y; Mukai T; Minami T; Toguchi H; Odomi M; Ogawara K; Higaki K; Kimura T
J Control Release; 2004 Sep; 99(1):63-71. PubMed ID: 15342181
[TBL] [Abstract][Full Text] [Related]
3. Optimization of suppository preparation containing sodium laurate and taurine that can safely improve rectal absorption of rebamipide.
Miyake M; Minami T; Oka Y; Kamada N; Yamazaki H; Kato Y; Mukai T; Toguchi H; Odomi M; Ogawara K; Higaki K; Kimura T
Biol Pharm Bull; 2006 Feb; 29(2):330-5. PubMed ID: 16462041
[TBL] [Abstract][Full Text] [Related]
4. Amino acids protect epithelial cells from local toxicity by absorption enhancer, sodium laurate.
Yata T; Endo Y; Sone M; Ogawara K; Higaki K; Kimura T
J Pharm Sci; 2001 Oct; 90(10):1456-65. PubMed ID: 11745705
[TBL] [Abstract][Full Text] [Related]
5. Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: utilization of polyamines and bile acids.
Miyake M; Minami T; Hirota M; Toguchi H; Odomi M; Ogawara K; Higaki K; Kimura T
J Control Release; 2006 Mar; 111(1-2):27-34. PubMed ID: 16410031
[TBL] [Abstract][Full Text] [Related]
6. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
[TBL] [Abstract][Full Text] [Related]
7. Amino acids suppress apoptosis induced by sodium laurate, an absorption enhancer.
Takayama C; Mukaizawa F; Fujita T; Ogawara K; Higaki K; Kimura T
J Pharm Sci; 2009 Dec; 98(12):4629-38. PubMed ID: 19630065
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cytoprotective effect of amino acids on local toxicity caused by sodium laurate, a drug absorption enhancer, in intestinal epithelium.
Endo Y; Hanada K; Miyake M; Ogawara K; Higaki K; Kimura T
J Pharm Sci; 2002 Mar; 91(3):730-43. PubMed ID: 11920758
[TBL] [Abstract][Full Text] [Related]
9. Involvement of intracellular Ca2+ dynamics in cytoprotective action by amino acids and cytotoxicity by sodium laurate, an absorption enhancer.
Okuda T; Kadotsuji K; Takayama C; Hanada K; Mukaizawa F; Ogawara K; Higaki K; Kimura T
J Pharm Sci; 2006 Oct; 95(10):2256-65. PubMed ID: 16886194
[TBL] [Abstract][Full Text] [Related]
10. [Safe improvement of drug absorption by combinatorial use of sodium laurate with amino acids: cytoprotection by amino acids and its mechanisms].
Higaki K
Yakugaku Zasshi; 2007 Apr; 127(4):589-99. PubMed ID: 17409688
[TBL] [Abstract][Full Text] [Related]
11. Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption.
Miyake M; Minami T; Toguchi H; Odomi M; Ogawara K; Higaki K; Kimura T
J Control Release; 2006 Oct; 115(2):130-3. PubMed ID: 16973235
[TBL] [Abstract][Full Text] [Related]
12. Novel oral absorption system containing polyamines and bile salts enhances drug transport via both transcellular and paracellular pathways across Caco-2 cell monolayers.
Mukaizawa F; Taniguchi K; Miyake M; Ogawara K; Odomi M; Higaki K; Kimura T
Int J Pharm; 2009 Feb; 367(1-2):103-8. PubMed ID: 18929635
[TBL] [Abstract][Full Text] [Related]
13. [Permeabilities of rebamipide via different intestinal mucosa in the diffusion chamber in vitro].
Li GF; Wang CX; Yan Y; Kishimoto N; Yamamoto A
Yao Xue Xue Bao; 2008 Mar; 43(3):314-7. PubMed ID: 18630271
[TBL] [Abstract][Full Text] [Related]
14. Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.
Kikuchi A; Tomoyasu T; Tanaka M; Kanamitsu K; Sasabe H; Maeda T; Odomi M; Tamai I
J Pharm Sci; 2009 May; 98(5):1775-87. PubMed ID: 18781650
[TBL] [Abstract][Full Text] [Related]
15. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
16. Lipid Nanoemulsions of Rebamipide: Formulation, Characterization, and In Vivo Evaluation of Pharmacokinetic and Pharmacodynamic Effects.
Narala A; Guda S; Veerabrahma K
AAPS PharmSciTech; 2019 Jan; 20(1):26. PubMed ID: 30604333
[TBL] [Abstract][Full Text] [Related]
17. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy.
Tung NT; Park CW; Oh TO; Kim JY; Ha JM; Rhee YS; Park ES
J Pharm Pharmacol; 2011 Dec; 63(12):1539-47. PubMed ID: 22060284
[TBL] [Abstract][Full Text] [Related]
18. Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate.
Wang X; Maher S; Brayden DJ
Ther Deliv; 2010 Jul; 1(1):75-82. PubMed ID: 22816121
[TBL] [Abstract][Full Text] [Related]
19. Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats.
Shin BS; Kim CH; Jun YS; Yoon CH; Rho JI; Lee KC; Han HS; Yoo SD
Drug Dev Ind Pharm; 2004 Sep; 30(8):869-76. PubMed ID: 15521332
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo.
Johnson LG; Vanhook MK; Coyne CB; Haykal-Coates N; Gavett SH
Hum Gene Ther; 2003 May; 14(8):729-47. PubMed ID: 12804137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
